好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2025 Annual Meeting | C170 - Diagnosis and Current Management of Cluster Headache and Other Primary Headache Disorders

Wednesday 04/09/25
07:00 AM - 09:00 AM PDT Add To Calendar
San Diego Convention Center | 4
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Stephanie J. Nahas, MD, FAAN
Headache
Participants should be able to diagnose, manage, and discuss cluster headache and other primary headache disorders.
 
This program is supported in part by an educational grant from Pfizer
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT Introduction Welcome
Stephanie J. Nahas, MD, FAAN
07:05 AM - 07:35 AM PDT Speaker Cluster Headache: Diagnosis, Pathophysiology, Management, and New Developments
Emmanuelle Schindler, MD, PhD
07:35 AM - 07:40 AM PDT Q&A Questions and Answers
Emmanuelle Schindler, MD, PhD
07:40 AM - 08:10 AM PDT Speaker Other Primary Headaches
Mario F. Peres, MD
08:10 AM - 08:15 AM PDT Q&A Questions and Answers
Mario F. Peres, MD
08:15 AM - 08:45 AM PDT Speaker Cases
Stephanie J. Nahas, MD, FAAN
08:45 AM - 09:00 AM PDT Q&A Questions and Answers
Stephanie J. Nahas, MD, FAAN
Faculty Disclosures
Stephanie J. Nahas, MD, FAAN Dr. Nahas has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AbbVie. Dr. Nahas has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a expert for CME activities with Medscape/WebMD. Dr. Nahas has a non-compensated relationship as a Board Member-at-Large with American Headache Society that is relevant to AAN interests or activities. Dr. Nahas has a non-compensated relationship as a Board Member-at-Large with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Dr. Nahas has a non-compensated relationship as a Executive Board Member with The Headache Alliance that is relevant to AAN interests or activities.
Emmanuelle Schindler, MD, PhD Dr. Schindler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. The institution of Dr. Schindler has received research support from National Headache Foundation. Dr. Schindler has received intellectual property interests from a discovery or technology relating to health care.
Mario F. Peres, MD Dr. Peres has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eurofarma. Dr. Peres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Peres has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Libbs. Dr. Peres has received research support from CNPq. Dr. Peres has received research support from Allergan.